The University of Birmingham is leading on major health research projects in Asia, Africa and Latin America to help develop surgical research that will have the potential to improve the quality of surgery.
Professor Pam Kearns, Director of the Cancer Research UK Clinical Trials Unit, is set to cycle 175 miles across England in just 12 hours to raise cash to help young cancer patients and their families.
University of Birmingham researchers are leading the way with a ground-breaking role to enable more children with the rare cancer neuroblastoma to access potentially life-saving clinical trials more quickly.
The Institute of Cancer and Genomic Sciences recently appointed Professor Colin Watts as Chair of the Birmingham Brain Cancer Programme.
A clinical trial testing a new treatment combination in patients with leukaemia launches through the Combinations Alliance, a joint initiative between Cancer Research UK and the Experimental Cancer Medicine Centres (ECMC) Network based at University of Birmingham.
The University of Birmingham and Guangzhou Women & Children's Medical Center today signed an agreement to establish a Joint Research Institute (JRI) that will use health data to help tackle childhood diseases.
Data science experts today signed an agreement to join forces with one of China's best hospitals to gather, organise and analyse patient information under related laws and regulations from both countries.
The University of Birmingham has won funding for a powerful new piece of technology called a spectrometer which will allow scientists to better gain insights into the molecular basis of human health.
Scientists in the College of Medical and Dental Sciences have been awarded nearly £3 million from Cancer Research UK to investigate cancers that are resistant to treatment.
Dr Rachel Bayley, a Research Fellow within the Institute of Cancer and Genomic Sciences.